Dopamine inhibits the Na+/H+ Exchanger NHE3 via Protein Phosphatase 2A
I. Alexandru Bobulescu(Southwestern Medical Center), Orson W. Moe(Io Therapeutics (United States)), Serge M. Gisler(University of Zurich), Henry Quiñones(The University of Texas Southwestern Medical Center), Daniel G. Fuster(University of Bern), Francesca Di Sole(The University of Texas Southwestern Medical Center), Mingjun Shi(Huazhong University of Science and Technology), Ming‐Chang Hu(The University of Texas Southwestern Medical Center), Jianning Zhang(Tianjin University of Technology), Marc C. Mumby
Cited by 0
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
|American Journal of Kidney Diseases|2018|644
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
Renal Transport of Uric Acid: Evolving Concepts and Uncertainties
|Advances in Chronic Kidney Disease|2012|394
Pathophysiologic basis for normouricosuric uric acid nephrolithiasis
|Kidney International|2002|346